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Abstract
Autism spectrum disorders (ASD) is a complex neurodevelopmental disorder that may significantly impact on the
affected individual’s life. Common variation (SNPs) could explain about 50% of ASD heritability. Despite this fact and
the large size of the last GWAS meta-analysis, it is believed that hundreds of risk genes in ASD have yet to be
discovered. New tools, such as TWAS (Transcriptome Wide Association Studies) which integrate tissue expression and
genetic data, are a great approach to identify new ASD susceptibility genes. The main goal of this study is to use
UTMOST with the publicly available summary statistics from the largest ASD GWAS meta-analysis as genetic input. In
addition, an in silico biological characterization for the novel associated loci was performed. Our results have shown
the association of 4 genes at the brain level (CIPC, PINX1, NKX2-2, and PTPRE) and have highlighted the association of
NKX2-2, MANBA, ERI1, and MITF at the gastrointestinal level. The gastrointestinal associations are quite relevant given
the well-established but unexplored relationship between ASD and gastrointestinal symptoms. Cross-tissue analysis
has shown the association of NKX2-2 and BLK. UTMOST-associated genes together with their in silico biological
characterization seems to point to different biological mechanisms underlying ASD etiology. Thus, it would not be
restricted to brain tissue and it will involve the participation of other body tissues such as the gastrointestinal.
Introduction
Autism spectrum disorders (ASD) includes a range of
neurodevelopmental disorders (NDDs) with onset in early
development that are characterized by deficits in com-
munication and social interactions, as well as by repetitive
patterns of behavior and restrictive interests1. ASD is a
complex genetic disorder, involving both environmental
and genetic factors. Although an important part of the
genetic architecture of ASD is unknown, it is considered
that thousands of genes may be involved even most of
them remain unidentified and functionally uncharacter-
ized. Rare genetic variation only explains 3% of ASD
genetic risk even if it confers a high individual risk2.
However, common variation (SNPs; single nucleotide
polymorphisms) could explain about 50% of ASD herit-
ability. The most recent and the largest ASD GWAS
meta-analysis done until now, including 18,381 ASD cases
and 27,969 controls, has reported 93 genome-wide sig-
nificant markers in three separate loci (top SNP: rs910805;
p-value: 2.04 × 10−9)3. Another methodological approach
for common variation are gene-based association analysis
(GBA) methods that employ the p-values for each
SNP within a gene to obtain a single statistic at this level.
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Thus, MAGMA has identified 15 genes, most of them
located near the genome-wide significant SNPs identified
in GWAS, but 7 genes have revealed association in four
additional loci (KCNN2, MMP12, NTM, and a cluster of
genes on chromosome 17)3. Additional GBA methods
using other algorithms as PASCAL have helped to define
the association of other genes located in the same LD
region than those found by MAGMA (NKX2-4, NKX2-2,
CRHR1-IT1, C8orf74, and LOC644172)4.
In addition to GBA, bioinformatic approaches that inte-
grate functional data are increasingly used to highlight new
genes underlying GWAS summary statistics. Transcriptome-
wide association studies (TWAS) have emerged as useful
tools to study the genetic architecture of complex traits.
Among them, MetaXcan5 and FUSION6 are well-known
TWAS methods.
UTMOST (unified test for molecular signatures) has
been recently reported as a novel framework for single
and cross-tissue expression imputation. UTMOST is able
to consider the joint effect of SNPs (summary statistics)
across LD regions (1000 Genomes) and to integrate tissue
expression data (GTeX) creating single and cross-tissue
covariance matrices that will help to define the gene-trait
associations. UTMOST performance was demonstrated at
several levels and its accuracy was also well proved as it
was able to identify a greater number of associations in
biologically relevant tissues for complex diseases7.
The main aim of this paper is to further mine the
summary data from the largest ASD meta-analysis using
UTMOST. In addition, an in silico biological character-
ization for the novel associated loci will be carried out
using bioinformatic approaches (DEG, pathway, gene
network, and an exploratory enhancer analysis).
Overall, our results have demonstrated the association
of CIPC, PINX1, NKX2-2, and PTPRE at the brain level
and have also revealed the relevance of gastrointestinal
tissue in ASD etiology through the association of other
genes (NKX2-2, MANBA, ERI1, and MITF).
Materials and methods
Datasets
Summary statistics from the latest ASD GWAS meta-
analysis were obtained from the public repository available
in the PGC website (http://www.med.unc.edu/pgc/results-
and-downloads). The following data set was employed:
iPSYCH_PGC_ASD_Nov2017.gz (Grove et al.3) which
includes the meta-analysis of ASD by the Lundbeck Foun-
dation Initiative for Integrative Psychiatric Research
(iPSYCH) and the Psychiatric Genomics Consortium (PGC)
released in November 2017. The data set comprises a total
of 18,381 cases and 27,969 controls. Additional information
about the genotyping, QC methods, and Ethics Commitees
as well as informed consents employed in are available at the
PGC website and in the previous Grove et al.3 study.
TWAS Analysis using UTMOST
UTMOST7 (https://github.com/Joker-Jerome/UTMOST)
was run as a single tissue association test for 44 GTeX tis-
sues (single_tissue_association_test.py) and a cross tissue
association test combining gene-trait associations was run
by the joint GBJ test (joint_GBJ_test.py). Both tests use the
previous summary statistics of the ASD GWAS meta-
analysis as an input3. UTMOST pre-calculated covariance
matrices for single-tissue (covariance_tissue/) and joint
test (covariance_joint/) were downloaded. Other necessary
command parameters were used by default. Transcriptome-
wide significance for single tissue analysis was established as
p-value= 3.85 × 10−6 (0.05/12984(maximum number of
genes tested) for brain tissues and p-value= 3.42 × 10−6
(0.05/14586 (maximum number of genes tested) for non-
brain tissues after Bonferroni correction. Transcriptome-
wide significance for joint test was established as p-value=
3.27 × 10−6 (0.05/15274) considering the number of effective
test (Tables 1–3) (Supplementary.csv files for each tissue).
Covariances matrices are only available for the 44 tissues of
GteX v6: adipose subcutaneous, adipose visceral omentum,
adrenal gland, artery aorta, artery coronary, artery tibial,
brain anterior cingulate cortex BA24, brain caudate basal
ganglia, brain cerebellar hemisphere, brain cerebellum, brain
cortex, brain frontal cortex BA9, brain hippocampus, brain
hypothalamus, brain nucleus accumbens basal ganglia,
brain putamen basal ganglia, breast mammary tissue, cells
EBV-transformed lymphocytes, cells transformed fibro-
blasts, colon sigmoid, colon transverse, esophagus gastro-
esophageal junction, esophagus mucosa, esophagus
muscularis, heart atrial appendage, heart left ventricle, liver,
lung, muscle skeletal, nerve tibial, ovary, pancreas, pituitary,
prostate, skin not sun-exposed suprapubic, skin sun-exposed
lower leg, small intestine, terminal ileum, spleen, stomach,
testis, thyroid, uterus, vagina, whole blood.
Morpheus software (https://software.broadinstitute.org/
morpheus/) was used to display the Z scores of UTMOST
significant genes across GTeX Brain tissues. UTMOST
significance as a Z score in brain tissues is ∼4.6. Gray
squares in the heatmap indicate that the gene weights
were not available in the target tissue (Fig. 1).
DEG and gene expression analysis with FUMA
GENE2FUNC, a tool of FUMA8 (https://fuma.ctglab.
nl/), was employed to carry out a gene expression heat-
map and an enrichment analysis of differentially brain
expressed genes (DEG) using BrainSpan RNA-seq data.
Those genes represented in Table 4 (bold: PTPRE, CIPC,
NKX2-2, PINX1) were used as an input. Expression
values are TPM (Transcripts Per Million) for GTEx v6
and RPKM (Read Per Kilobase per Million). In order to
define DEG sets, two-sided Student’s t-test were per-
formed for these genes and per tissue against the dif-
ferent tissue types or developmental stages. Those genes
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with a p-value < 0.05 after Bonferroni correction and a
log fold change ≥0.58 are defined as DEG. The direction
of expression was considered. The −log10 (p-value)
refers to the probability of the hypergeometric test DEG
analysis was carried out creating differentially expressed
genes for each expression data set (Fig. 2). Heatmaps
display the normalized expression value (zero mean
normalization of log2 transformed expression), and
darker red means higher relative expression of that gene
in each label, compared to a darker blue color in the
same label (Fig. 3).
GeneMANIA and Metascape analysis
GeneMANIA9 (https://genemania.org/) was used to
build a gene network for the UTMOST-associated genes
by the single tissue analysis (brain and gastrointestinal
tissues) and by the joint tissue analysis (Table 4). Each
gene-network was subsequently analyzed with Metascape
(https://metascape.org/)10 to carry out a pathway enrich-
ment and a protein–protein interaction enrichment using
the Evidence Counting (GPEC) prioritization tool. For
each given gene list, pathway and process enrichment
analysis has been carried out with the following ontology
sources: GO biological processes, GO cellular compo-
nents and GO molecular functions. The enrichment
background includes all the genes in the genome. Terms
with a p-value < 0.01, a minimum count of 3, and an
enrichment factor >1.5 (the enrichment factor is the ratio
between the observed counts and the counts expected by
chance) are collected and grouped into clusters based on




























































































































































































































































































































































































Fig. 1 Heatmap representing UTMOST significant genes across
weight sets and brain areas. UTMOST significance as a Z score is
~4.6. Gray squares indicate that gene weights were not available in
the target tissue.
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are calculated based on the accumulative hypergeometric
distribution, and q-values are calculated using the
Benjamini–Hochberg procedure to account for multiple
testings. Kappa scores are used as the similarity metric
when performing hierarchical clustering on the enriched
terms, and sub-trees with a similarity of >0.3 are con-
sidered a cluster. We select the terms with the best
p-values from each of the 20 clusters, with the constraint
that there are no more than 15 terms per cluster and no
more than 250 terms in total (Figs. 4–6). The network is
Fig. 2 DEG analysis for PTPRE, CIPC, PINX1 and NKX2-2. a DEG using BrainSpan 11 general developmental stages of brain samples and b DEG
using BrainSpan 29 different ages of brain data. There are not significantly enriched DEG sets.
Fig. 3 Gene expression heatmaps for PTPRE, CIPC, PINX1 and NKX2-2. a Gene expression heatmap using BrainSpan 11 general developmental
stages of brain samples and b BrainSpan 29 differentes ages of brain data. Genes are ordered by expression clusteres and brain samples and ages by
alphabetical order.
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Fig. 4 Gene networks, enriched ontology clusters, and PPI interaction analysis fot the brain-associated genes (CIPC, PINX1, NKX2-2, and
PTPRE) by UTMOST (single tissue analysis). a GeneMania gene network. b Bar graph of enriched terms across input gene lists, colored by p-values.
c Network of enriched terms: colored by cluster ID, where nodes that share the same cluster ID are typically close to each other. d Protein–protein
interaction network and MCODE components identified in the gene lists. (MCODE1:red).
Table 2 UTMOST Single tissue analysis (Non Brain tisues).
Loci Location hg19 MinP (UTMOST) Tissue Z score SNPs in model Other associations GWAS, GBA and/
or TWAS
NKX2-2* chr20:21491660-21494664 5.28 × 10−6 Colon transverse −4.55 2 Grove et al./Alonso-Gonzalez et al.
MANBA chr4:103552643-
103682151
3.2 × 10−6 Esophagus
muscularis
4.66 47 –
ERI1* chr8:8860314-8890849 3.84 × 10−6 Esophagus
muscularis
4.62 124 –
DOK5 chr20:53092266-53267710 4.86 × 10−7 Liver −409.74 4 –
ATXN1 chr6:16299343-16761721 2.4 × 10−6 Nerve tibial −4.72 27 –
FERMT2 chr14:53323989-53417815 3.1 × 10−6 Skin not sun
exposed
−5.49 14 –
MITF chr3:69788586-70017488 2.34 × 10−6 Stomach 4.72 111 –
CTSB chr8:11700034-11725646 3.36 × 10−6 Thyroid 4.65 66 –
ANGEL1 chr14:77253586-77279283 1.89 × 10−6 Uterus 4.76 83 –
List of independent significant loci.
Bonferroni threshold= 3.42 × 10−6.
Genes in bold are associated within gastrointestinal tissues.
GWAS genome-wide association study, SNP single nucleotide polymorphism, TWAS transcriptome-wide association study.
*Marginally significant.
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visualized using Cytoscape, where each node represents
an enriched term and is colored first by its cluster ID (or
each given gene list, protein–protein interaction enrich-
ment analysis has been carried out with the following
databases: BioGrid6, InWeb_IM7, OmniPath8. The
resultant network contains the subset of proteins that
form physical interactions with at least one other member
in the list. If the network contains between 3 and 500
proteins, the Molecular Complex Detection (MCODE)
algorithm has been applied to identify densely connected
network components. The MCODE networks identified
for individual gene lists are shown in Figs. 4–6.
Enhancer analysis (dbSUPER)
dbSUPER (https://asntech.org/dbsuper/) was used to
perform an exploratory enhancer analysis for the
UTMOST-associated genes (single-tissue analysis) and
for those tissues (brain and gastrointestinal) available at
dbSUPER. The parameters selected were: SEs ranking
method (H3K27ac), the peak calling was done with MACS
(version 1.4.1) with parameters -p 1e-9,-keep-dup= auto,
-w -S -space= 50, the stitching distance was established
at 12,5 kb, the TSS exclusive zone was set at ±2 kb
and the enhancer gene assignment was done within a
50 kb window.
Results and discussion
UTMOST analyses and comparison with previous results
UTMOST single tissue analysis (Brain tissues) showed
association of two loci, NKX2-2 and PTPRE, while other
two loci, CIPC and PINX1, showed a marginal association
according to Bonferroni threshold (Table 1, Supplemen-
tary.csv files). NKX2-2 was previously identified as an
associated gene by two different GBA algorithms,
MAGMA, and PASCAL3,4. The results obtained by
UTMOST also serve to indicate the nucleus accumbens
basal ganglia as the brain area in which these genes may
be acting. Although the association of PTPRE was not
obtained as such in previous analyses, the association of
its neighboring gene, C8orf74, was noted in a previous
study and one of the index SNPs in the latest ASD GWAS
was located near PINX1 (rs10099100) (Supplementary
Fig. 1a, b)3,4.
NKX2-2 was also marginally associated by UTMOST
within non-brain tissue together with other genes. It
should be noted that some genes are tissue-specific for
gastric and intestinal tissues such as stomach, esophagus
and colon (MANBA, ERI1, MITF, and NKX2-2). The
association of NKX2-2 in colon is noteworthy because
NKX2-2 was previously reported as an ASD risk gene and
Table 3 UTMOST Cross tissue analysis.
Loci Location hg19 MinP (UTMOST) test score Other associations GWAS, GBA and/or TWAS
BLK chr8:11351521-11422108 2.85 × 10−6 12.3 Grove et al.
NKX2-2 chr20:21491660-21494664 3.7 × 10−7 13.9 Grove et al./Alonso-Gonzalez et al.
List of independent significant loci.
Bonferroni threshold= 3.27 × 10−6.
GWAS genome-wide association study, SNP single nucleotide polymorphism, TWAS transcriptome-wide association study.
Table 4 List of associated genes for each analysis (bold)
and their predicted GeneMANIA interactors that were used
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now it is highlighted again by UTMOST in brain tissues.
It seems that NKX2-2 together with BLK may play a role
in ASD etiology but not only at the brain level since
UTMOST cross-tissue analysis also found association for
both genes (Tables 2, 3, Supplementary Figs. 1a, 2a, b,
Supplementary.csv files)
To evaluate the importance of each brain tissue in
ASD etiology, a secondary analysis was performed using
Table 5 Top 11 clusters with their representative enriched terms (one per cluster) for the associated genes (CIPC PINX1,
NKX2-2, and PTPRE) (Single tissue analysis (Brain)) and their interactors.
GO Category Description Count % Log10(P) Log10(q)
GO:0007004 GO Biological processes Telomere maintenance via telomerase 7 43.75 −13.85 −9.50
GO:0031018 GO Biological processes Endocrine pancreas development 6 26.09 −11.54 −8.33
GO:0051347 GO Biological processes Positive regulation of transferase activity 8 50.00 −8.34 −5.76
GO:0070851 GO Molecular functions Growth factor receptor binding 5 31.25 −7.69 −5.24
GO:0031647 GO Biological processes Regulation of protein stability 6 26.09 −6.61 −4.30
GO:0051098 GO Biological processes Regulation of binding 6 26.09 −6.00 −3.83
GO:0010035 GO Biological processes Response to inorganic substance 6 37.50 −5.98 −3.83
GO:0019904 GO Molecular functions Protein domain specific binding 6 37.50 −5.40 −3.36
GO:0050999 GO Biological processes Regulation of nitric−oxide synthase activity 3 18.75 −5.31 −3.29
GO:0009636 GO Biological processes Response to toxic substance 6 26.09 −5.08 −3.10
GO:0019932 GO Biological processes Second-messenger-mediated signaling 4 17.39 −3.12 −1.51
“Count” is the number of genes in the user-provided lists with membership in the given ontology term. “%“ is the percentage of all of the provided genes that are
found in the given ontology term (only input genes with at least one ontology term annotation are included in the calculation). “Log10(P)” is the p-value in log base
10. “Log10(q)” is the multi-test adjusted p-value in log base 10.
Table 6 Protein–protein interaction network and MCODE components identified in the gene lists for the associated
genes (CIPC PINX1, NKX2-2, and PTPRE) (Single tissue analysis (Brain)) and their interactors.
GO Description Log10(P) MCODE GO Description Log10(P)
GO:0007004 Telomere maintenance via
telomerase
−13.0 MCODE_1 GO:0007169 Transmembrane receptor protein tyrosine kinase
signaling pathway
−4.5
GO:0006278 RNA-dependent DNA biosynthetic
process
−12.7 MCODE_2 GO:0007004 Telomere maintenance via telomerase −7.6
MCODE_2 GO:0006278 RNA-dependent DNA biosynthetic process −7.5
GO:0010833 Telomere maintenance via telomere
lengthening
−12.5 MCODE_2 GO:0010833 Telomere maintenance via telomere lengthening −7.4
Table 7 Top 4 clusters with their representative enriched terms (one per cluster) fot the associated genes by UTMOST
Single tissue analysis (GI tissues) (NKX2-2, MANBA, ERI1, and MITF) and their predicted interactors.
GO Category Description Count % Log10(P) Log10(q)
GO:0000978 GO Molecular functions RNA polymerase II proximal promoter sequence-specific DNA binding 12 57.14 −13.89 −9.63
GO:0021778 GO Biological processes Oligodendrocyte cell fate specification 3 25.00 −9.03 −5.82
GO:0048066 GO Biological processes Developmental pigmentation 4 33.33 −8.21 −5.12
GO:0008134 GO Molecular functions Transcription factor binding 6 28.57 −4.81 −2.47
“Count” is the number of genes in the user-provided lists with membership in the given ontology term. “%“ is the percentage of all of the provided genes that are
found in the given ontology term (only input genes with at least one ontology term annotation are included in the calculation). “Log10(P)” is the p-value in log base
10. “Log10(q)” is the multi-test adjusted p-value in log base 10.
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Z scores values for each ASD-associated gene across
GTeX brain tissues. The heatmap showed that there is a
wide specificity of association in terms of Z score for each
gene and brain tissue indicating the importance of con-
ducting tissue specific analyses such as UTMOST (Fig. 1).
DEG analysis with GENE2FUNC tool (FUMA)
DEG Analysis with BrainSpan data (11 general devel-
opmental stages of brain samples and 29 different ages of
brain samples) for the brain associated set of genes have
not shown any significant result (Fig. 2a, b). However,
CIPC have shown overexpression across every single
developmental stage in comparison with the remaining
ASD-associated genes (Fig. 3a, b).
GeneMANIA and Metascape analysis
GeneMANIA was used to find out the possible inter-
actors with the associated genes (Table 4). We have
proposed three different analyses. One based on the
genes associated in brain tissues; another one based on
Table 8 Protein–protein interaction network and MCODE components identified in the gene lists for the GI associated
genes (and their interactors.
GO Description Log10(P) MCODE GO Description Log10(P)
GO:0000978 RNA polymerase II proximal promoter sequence-
specific DNA binding
−11.2 MCODE_1 GO:0035497 cAMP response element binding −9.8
GO:0000987 proximal promoter sequence-specific DNA
binding
−11.0 MCODE_1 GO:0030968 Endoplasmic reticulum unfolded
protein response
−6.9
GO:0001228 DNA-binding transcription activator activity, RNA
polymerase II-specific
−10.8 MCODE_1 GO:0034620 Cellular response to unfolded protein −6.7
Fig. 5 Gene networks, enriched ontology clusters for the associated genes by UTMOST single tissue analysis (gastrointestinal tissues) and
their predicted interactors (NKX2-2, MANBA, ERI1, MITF). a GeneMania gene network. b Bar graph of enriched terms across input gene lists,
colored by p-values. c Network of enriched terms: colored by cluster ID, where nodes that share the same cluster ID are typically close to each other.
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the associated genes at a gastrointestinal level, given the
associations pointed out by UTMOST and the previous
implications of gastrointestinal abnormalities and
symptoms in ASD and the lack of biological knowledge
about them. The final analysis is focused on the genes
identified by the cross-tissue analysis and their inter-
actors. The general goal is to delineate the biological
pathways underlying each group of genes and the dif-
ferences between them.
Gene network, enriched ontology clusters, and PPI
interaction analysis for the brain-associated genes (CIPC,
PINX1, NKX2-2, and PTPRE) by UTMOST Single tissue
analysis and their interactors highlights different biologi-
cal pathways mainly involved in telomere maintenance
and transcription regulation (Tables 5, 6 and Fig. 4).
However, associated genes in gastrointestinal tissue
(NKX2-2, MANBA, ERI1, and MITF) and their interactors
mainly regulate DNA transcription by RNA polymerase II
and the fate of oligodendrocytes. This is an interesting
finding given the possible involvement of these cells in the
enteric nervous system in ASD (Tables 7, 8 and Fig. 5).
Finally, NKX2-2 and BLK both associated in the cross-
tissue analysis, seem to point to very diverse biological
pathways such as protein tyrosine kinase activity, B cell
receptor complex, regulation of DNA-binding transcrip-
tion factor activity, and neuron projection morphogenesis,
among others (Tables 8–10 and Fig. 6).
Enhancer analysis (dbSUPER)
Given the tissue specificity given by UTMOST asso-
ciations, we found interesting to perform an exploratory
analysis of enhancers. According to the dbSUPER dabase
only CIPC could work as a superenhancer in the brain
middle hippocampus (SE_06106; chr14: 77562660-
77607123, size: 44463 pb) (Supplementary Fig. 3).
As far as we know, this is the first study that has
employed the UTMOST framework combined with the
summary statistics of the largest ASD meta-analysis. The
main aim was to identify ASD tissue-specific genes in
brain and/or other tissues. It should be noted at the outset
that gene-level associations identified by UTMOST do
not imply causality. However, looking at the regional plots
for each loci associated by UTMOST, the results shown at
brain and gastrointestinal level seems pretty consistent.
Thus, UTMOST has served to identify new ASD-
associated genes in brain tissues as PTPRE and CIPC.
Furthermore, UTMOST has been useful to confirm and
obtain information on the tissue in which other known
ASD risk genes such as NKX2-2 and PINX1 may have
functional relevance. Altogether, brain-associated genes
seems to point to three brain areas: cortex, hippocampus
and nucleo accumbens. Previous studies demonstrated
the ASD-associated gene expression in brain cortex11. In
addition, hippocampus underlie some of the featured
social memory and cognitive behaviors both crucial
aspects in ASD12. The nucleus accumbens is a key brain
area also related with the social reward response in
ASD13. It should be also noted some limitations of our
study. UTMOST uses GTeX v6 data by default and it
should be interesting to re-run the analysis once the tool
will be updated. Thus, UTMOST could find novel asso-
ciated genes when expression data from other relevant
ASD brain tissues as the amygdala are included. Another
limitation of our results is the small number of SNPs
Table 9 Top 11 clusters with their representative enriched terms (one per cluster) fot the associated genes by UTMOST
Cross Tissue Analysis (BLK and NKX2-2) and their predicted interactors.
GO Category Description Count % Log10(P) Log10(q)
GO:0004713 GO Molecular functions Protein tyrosine kinase activity 6 42.86 −10.03 −5.68
GO:0031018 GO Biological processes Endocrine pancreas development 5 25.00 −9.57 −5.64
GO:0019815 GO Cellular components B cell receptor complex 3 21.43 −9.21 −5.56
GO:0051090 GO Biological processes Regulation of DNA-binding transcription factor activity 7 35.00 −7.40 −4.63
GO:0030072 GO Biological processes Peptide hormone secretion 6 30.00 −7.37 −4.63
GO:0007263 GO Biological processes Nitric oxide mediated signal transduction 3 21.43 −6.25 −3.89
GO:0048812 GO Biological processes Neuron projection morphogenesis 7 35.00 −6.21 −3.87
GO:0051897 GO Biological processes Positive regulation of protein kinase B signaling 4 20.00 −4.91 −2.92
GO:0019904 GO Molecular functions Protein domain specific binding 5 35.71 −4.45 −2.58
GO:0072507 GO Biological processes Divalent inorganic cation homeostasis 4 18.18 −2.92 −1.26
GO:0001568 GO Biological processes Blood vessel development 4 18.18 −2.31 −0.69
“Count” is the number of genes in the user-provided lists with membership in the given ontology term. “%“ is the percentage of all of the provided genes that are
found in the given ontology term (only input genes with at least one ontology term annotation are included in the calculation). “Log10(P)” is the p-value in log base
10. “Log10(q)” is the multi-test adjusted p-value in log base 10.
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considered by UTMOST to create the statistic in some
genes (PTPRE in brain tissues and NKX2-2 in non-brain
tissues analysis). However, we have been very conservative
in establishing Bonferroni correction for all tissues in an
analysis group. Thus, for example, we always chose the
maximum number of genes tested in one of the brain
tissues and applied this to calcule Bonferroni for the
whole group of brain tissues as a whole.
In relation to the biological pathways in which
UTMOST-associated genes are involved, our results
open possible avenues for future genetic and functional
studies. Thus, the functional role in ASD of CIPC,
PINX1, NKX2-2, and PTPRE has not yet been char-
acterized in detail. Metascape analysis have provided an
insight revealing their involvement in telomerase main-
tenance and transcription regulation. Thus, PINX1
(PIN2 (TERF1) Interacting Telomerase Inhibitor 1)
enhances TRF1 binding to telomeres and inhibits telo-
merase activity. It was proved that its silencing com-
promises telomere length maintenance in cancer
cells14. In addition, it was recently found that children
with ASD and sensory symptoms have shorter telomeres,
compared to those children exhibiting a typical devel-
opment15. CIPC (CLOCK interacting pacemaker) is a
Table 10 Protein–protein interaction network and MCODE components identified in the gene lists for the cross analysis
associated genes and their interactors.
GO Description Log10(P) MCODE GO Description Log10(P)
GO:0030183 B cell differentiation −9.6 MCODE_1 GO:0030183 B cell differentiation −9.1
GO:0004713 Protein tyrosine kinase activity −9.4
GO:0007169 Transmembrane receptor protein tyrosine kinase signaling
pathway




Fig. 6 Gene network, enriched ontology clusters, and PPI interaction analysis for the associated genes by UTMOST cross. tissue analysis
(BLK and NKX2-2) and their interactors. a GeneMania gene network. b Bar graph of enriched terms across input gene lists, colored by p-values.
c Network of enriched terms: colored by cluster ID, where nodes that share the same cluster ID are typically close to each other. d Protein–protein
interaction network and MCODE components identified in the gene lists (MCODE1:red).
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mammalian circadian clock protein. Recently, circadian
rithms were pointed out as involved in brain develop-
ment and they could underly ASD etiology due to its
implication in behavioral processes. Circadian rythms
are regulated through several transcription factors in
different cellular types, fact that might be related
with the GO terms associated with transcription reg-
ulation in this study16. Moreover, the result of CIPC as a
predicted superenhancer highlights its possible func-
tional repercussion.
UTMOST found association of several genes in non-
brain tissues. However, we found really interesting to
study those genes related to gastrointestinal tissues
(NKX2-2, MANBA, ERI1, and MITF). There is a well-
known and established comorbidity among gastro-
intestinal symptoms and ASD17. These clinical associa-
tions suggest the implication of gastrointestinal
populations of neuronal cells. A mutation in NLGN3
(R451C) has been recently identified in two ASD
brothers with GI symptoms. Mice models have demon-
strated that R451C alter the number of neuronal cells in
the small intestine and impact fecal microbes18. These
evidence suggest that the role of NKX2-2, MANBA,
ERI1, and MITF in gastrointestinal tissue should be
further studied.
BLK and NKX2-2 are both associated in the cross-tissue
analysis. The importance of UTMOST approach is that is
able to show the association of two previously known
ASD risk genes but not restricted to brain tissue. These
findings lead to a difficult question whether autism can be
a multisystemic disorder, something that has been
recently pointed out by some authors19.
In conclusion, UTMOST, a novel single and cross-tissue
TWAS, has revealed new ASD-associated genes. These
genes have been characterized at the pathway and gene
network level using bioinformatic approaches. However,
future tissue-specific functional studies will be key to
properly determine their role in ASD etiology.
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